Prima BioMed Ltd
(NASDAQ: PBMD)
2.27
+0.26
+12.94%
MORE ON PBMD
| 2012 | 2011 | ||||
| Period End Date | 06/30/2012 | 06/30/2011 | |||
| Stmt Source | N/A | N/A | |||
| Stmt Source Date | 06/30/2012 | 10/03/2012 | |||
| Stmt Update Type | Original | Updated | |||
| Currency Code | AUD | AUD | |||
| Net Income | -19.9 | -21.1 | |||
| Operating Gains/Losses | 0.1 | 0.0 | |||
| Depreciation,Amortization and Depletion | 0.4 | 0.1 | |||
| 0.2 | 8.1 | ||||
| Stock-Based Compensation | 0.3 | 7.5 | |||
| Change in Receivables | -0.2 | 0.0 | |||
| Change in Inventories | 0.0 | -0.2 | |||
| 0.4 | 1.0 | ||||
| Change in Payables | 0.4 | 1.0 | |||
| Change in Accrued Expenses | 0.1 | 0.0 | |||
| Change in Other Working Capital | 0.0 | -0.7 | |||
| Cash Flow from Operating Activities | -19.1 | -12.8 | |||
| -0.6 | 0.0 | ||||
| Purchase of Property,Plant and Equipment | -0.6 | 0.0 | |||
| Other Investing Changes,Net | -11.0 | 0.0 | |||
| Cash Flow from Investing Activities | -11.6 | 0.0 | |||
| 0.0 | 5.4 | ||||
| 0.0 | 5.4 | ||||
| Proceeds or Issuance of Long Term Debt | 0.0 | 5.4 | |||
| 1.8 | 49.7 | ||||
| Proceeds or Issuance of Common Stock | 1.8 | 49.7 | |||
| Other Financing Changes, Net | 0.0 | -1.9 | |||
| Cash Flow from Financing Activities | 1.8 | 53.1 | |||
| Cash, Equivalents, Start of Period | 45.9 | 5.6 | |||
| Cash, Equivalents, End of Period | 17.0 | 45.9 | |||
| Change in Cash | -28.9 | 40.3 | |||
| Free Cash Flow | -19.7 | -12.9 | |||
DATA PROVIDERS
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.




